InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,141.20
(
0.96%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.03
(
-0.14%
)
Bitcoin
64,467.49
(
-0.03%
)
Post# of 402582
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Here Today

Send PM Follow Ignore
Followers 70
Posts 11221
Boards Moderated 0
Alias Born 01/05/2018

Here Today

Member Level

Re: None

Tuesday, 03/24/2020 5:35:07 PM

Tuesday, March 24, 2020 5:35:07 PM

Post# of 402582
An email — covid19@ipharminc.com — has been set up by the Company to receive inbound inquiries regarding Brilacidin as a potential novel treatment for COVID-19.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM

Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM

North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM

Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM

Start posting your company's news
Only $200 per official company press release!